ALL THE LATEST STEM CELL RESEARCH, CORD BLOOD BANKING, ADULT STEM CELLS, STEM CELL THERAPY, REGENERATIVE MEDICINE AND MEDICAL SCIENCE NEWS IN MALAYSIA & THE REST OF THE WORLD.
Saturday, May 23, 2009
Stem Cell Treatment For ALS or Lou Gehrig’s Disease Proven Effective
Amyotrophic lateral sclerosis (ALS), often called “Lou Gehrig’s Disease,” is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. As motor neurons degenerate, they can no longer send the impulses to the muscle fibers that would usually result in muscle movement. Approximately 5,600 people in the U.S. are diagnosed with ALS each year. The incidence of ALS is two per 100,000 people, and it is estimated that as many as 30,000 Americans may have Lou Gehrig’s Disease.
At this time there is no treatment to control ALS except FDA approved Riluzole, which somewhat slows the progression of the illness.
Recent research has shown that autologous stem cell therapy can effectively improve the condition of patients who are suffering from ALS. From a study in Thailand, from the use electroneuromyography, nine out of thirteen patients shown significant improvements. Brian Dardzinski, Returning Hope’s CEO, was excited about the result of this trial which proves the efficacy of stem cell treatment against ALS.
Source: stemcellumbillicalcordblood.com 20 May 2009
Our Supporting Partner - StemTECH International Sdn Bhd is dedicated and committed to cord blood and adult stem cell banking (collection/harvesting,procesing and storage), stem cell medical therapy, as well as R & D for the purpose of future stem cell technology, improvements, medical therapy and overall betterment of everyone. StemTECH International offers all Malaysians a personalised service with cutting-edge technologies and the most secured facilities available in this region.
Quote from StemTECH International... "We believe that cord blood stem cell banking should be made available to each and every newborn. For this reason, and placing medical interest ahead of commercial interest, we constantly strive to provide high quality service with our cutting-edge laboratory facilities giving the best value to all who demands it!" StemTECH International's Person In Charge is Professor Dr Menaka